Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, July 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 270 articles:
HTML format


 

Single Articles

  1. WANG Y, Chen A, Zheng C, Zhao L, et al
    miR-92a promotes cervical cancer cell proliferation, invasion, and migration by directly targeting PIK3R1.
    J Clin Lab Anal. 2021 Jul 3:e23893. doi: 10.1002/jcla.23893.
    PubMed    
    Abstract available

  2. R E, V S, V V, Mahanti A, et al
    Cervical Cancer Diagnostics Healthcare System Using Hybrid Object Detection Adversarial Networks.
    IEEE J Biomed Health Inform. 2021;PP.
    PubMed    
    Abstract available

  3. CARVAJAL F, Carvajal C, Merino T, Lopez V, et al
    Radiotherapy for cervical cancer: Chilean consensus of the Society of Radiation Oncology.
    Rep Pract Oncol Radiother. 2021;26:291-302.
    PubMed    
    Abstract available

  4. LI Q, Zhou ZW, Duan W, Qian CY, et al
    Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT.
    J Exp Clin Cancer Res. 2021;40:220.
    PubMed    
    Abstract available

  5. MEDEIROS R, Horta B, Freitas-Silva J, Silva J, et al
    Effect of 1-Carbaldehyde-3,4-dimethoxyxanthone on Prostate and HPV-18 Positive Cervical Cancer Cell Lines and on Human THP-1 Macrophages.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  6. ALOMARI M, Almahasheer A, Jermy BR, Al-Dossary AA, et al
    Impact of Poly (Styrene-Acrylic Acid) Latex Nanoparticles on Colorectal and Cervical Cancer Cells.
    Polymers (Basel). 2021;13.
    PubMed    
    Abstract available

  7. ACEVEDO-SANCHEZ V, Rodriguez-Hernandez RM, Aguilar-Ruiz SR, Torres-Aguilar H, et al
    Extracellular Vesicles in Cervical Cancer and HPV Infection.
    Membranes (Basel). 2021;11.
    PubMed    
    Abstract available

  8. UDOMWAN P, Pientong C, Tongchai P, Burassakarn A, et al
    Proteomics Analysis of Andrographolide-Induced Apoptosis via the Regulation of Tumor Suppressor p53 Proteolysis in Cervical Cancer-Derived Human Papillomavirus 16-Positive Cell Lines.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  9. SODEIKAT P, Lia M, Martin M, Horn LC, et al
    The Importance of Clinical Examination under General Anesthesia: Improving Parametrial Assessment in Cervical Cancer Patients.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  10. TEMIZ E, Koyuncu I, Durgun M, Caglayan M, et al
    Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  11. LIU PL
    Linking digital health divide to HPV awareness, HPV knowledge, and cervical cancer screening among women in the United States: A trend analysis from 2008 to 2017.
    Health Care Women Int. 2021 Jul 1:1-14. doi: 10.1080/07399332.2021.1931223.
    PubMed    
    Abstract available

  12. MA J, Yang L, Feng H, Zheng L, et al
    CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
    J Clin Lab Anal. 2021 Jul 1:e23793. doi: 10.1002/jcla.23793.
    PubMed    
    Abstract available

  13. XIAO L, Zhu H, Shu J, Gong D, et al
    Overexpression of TGF-beta1 and SDF-1 in cervical cancer-associated fibroblasts promotes cell growth, invasion and migration.
    Arch Gynecol Obstet. 2021 Jul 1. pii: 10.1007/s00404-021-06137.
    PubMed    
    Abstract available

  14. NKURUNZIZA C, Ghebre R, Magriples U, Ntasumbumuyange D, et al
    Healthcare provider challenges to early detection of cervical cancer at primary healthcare level in Rwanda.
    Gynecol Oncol Rep. 2021;37:100810.
    PubMed    
    Abstract available

  15. KUDELA E, Liskova A, Samec M, Koklesova L, et al
    The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.
    EPMA J. 2021;12:199-220.
    PubMed    
    Abstract available

  16. SETHI S, Poirier B, Canfell K, Smith M, et al
    Working towards a comprehensive understanding of HPV and cervical cancer among Indigenous women: a qualitative systematic review.
    BMJ Open. 2021;11:e050113.
    PubMed    
    Abstract available

  17. QURESHI SA, Igland J, Moen K, Gele A, et al
    Effect of a community-based intervention to increase participation in cervical cancer screening among Pakistani and Somali women in Norway.
    BMC Public Health. 2021;21:1271.
    PubMed    
    Abstract available

  18. ZHAO FH, Ren WH
    [Accelerating the elimination of cervical cancer in China and building a paradigm for "Healthy China" cancer prevention].
    Zhonghua Yi Xue Za Zhi. 2021;101:1831-1834.
    PubMed    
    Abstract available

  19. REN WH, Zhao XL, Zhao FH
    [Global guidelines for cervical cancer screening: a systematic review].
    Zhonghua Yi Xue Za Zhi. 2021;101:1882-1889.
    PubMed    
    Abstract available

  20. ZHAO YX, Ma L, Ren WH, Song B, et al
    [Analysis of the reported data of National Cervical Cancer Screening Program in Rural Areas in China from 2009 to 2018].
    Zhonghua Yi Xue Za Zhi. 2021;101:1863-1868.
    PubMed    
    Abstract available

  21. ZHANG M, Bao HL, Wang LM, Zhao ZP, et al
    [Analysis of cervical cancer screening and related factors in China].
    Zhonghua Yi Xue Za Zhi. 2021;101:1869-1874.
    PubMed    
    Abstract available

  22. HAMERS FF, Poullie AI, Arbyn M
    Updated evidence-based recommendations for cervical cancer screening in France.
    Eur J Cancer Prev. 2021 Jun 28. pii: 00008469-900000000-99034.
    PubMed    
    Abstract available

  23. SAVULESCU AF, Cirlan C, Simionescu AA, Budrugeac AI, et al
    Fibrosis Associated with Retroperitoneal Abscess after Multimodal Treatment of Cervical Carcinoma - A Case Report and Brief Review of the Literature.
    Chirurgia (Bucur). 2021;116:361-367.
    PubMed    
    Abstract available

  24. YANG Y, Liu Y, Liu W, Li C, et al
    miR-122 Inhibits the Cervical Cancer Development by Targeting the Oncogene RAD21.
    Biochem Genet. 2021 Jun 30. pii: 10.1007/s10528-021-10098.
    PubMed    
    Abstract available

  25. GRIMES DR, Corry EMA, Malagon T, O'Riain C, et al
    Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination.
    JAMA Netw Open. 2021;4:e2115321.
    PubMed    
    Abstract available

  26. WANG Y, Shen F, Zhou J, Fang Y, et al
    Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagy.
    Drug Dev Res. 2021 Jun 30. doi: 10.1002/ddr.21852.
    PubMed    
    Abstract available

  27. MUMBA JM, Kasonka L, Owiti OB, Andrew J, et al
    Dataset evaluating the treatment timeliness of cervical cancer in Zambia.
    Data Brief. 2021;37:107201.
    PubMed    
    Abstract available

  28. CAO S, Li H, Li L
    LncRNA SNHG17 Contributes to the Progression of Cervical Cancer by Targeting microRNA-375-3p.
    Cancer Manag Res. 2021;13:4969-4978.
    PubMed    
    Abstract available

  29. MILLER H, Matsuo KM, Roman LD, Yessaian AA, et al
    Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery.
    Radiat Oncol. 2021;16:123.
    PubMed    
    Abstract available

  30. TAFADZWA D, Julien R, Lina B, Eliane R, et al
    Spatiotemporal modelling and mapping of cervical cancer incidence among HIV positive women in South Africa: a nationwide study.
    Int J Health Geogr. 2021;20:30.
    PubMed    
    Abstract available

  31. JOHN-AKINOLA YO, Oluwasanu MM, Oladepo O
    Urban Poor Community Settings' Knowledge and Screening Practices for Cervical Cancer in Ibadan, Nigeria.
    JCO Glob Oncol. 2021;7:1024-1031.
    PubMed    
    Abstract available

  32. DONG S, Lu Q, Xu P, Chen L, et al
    Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening.
    Clin Transl Med. 2021;11:e457.
    PubMed    


  33. HOU Y, Fan Y, Xia X, Pan J, et al
    USP31 acetylation at Lys1264 is essential for its activity and cervical cancer cell growth.
    Acta Biochim Biophys Sin (Shanghai). 2021 Jun 29. pii: 6311107.
    PubMed    
    Abstract available

  34. ROWINSKI E, Magne N, Bouleftour W, Moreno-Acosta P, et al
    Genetic Analysis in Anal and Cervical Cancer: Exploratory Findings About Radioresistance in the ProfiLER Database.
    Cancer Genomics Proteomics. 2021;18:515-520.
    PubMed    
    Abstract available


  35. Statement of Retraction: DGUOK-AS1 promotes the proliferation cervical cancer through regulating miR-653-5p/EMSY.
    Cancer Biol Ther. 2021 Jun 29:1. doi: 10.1080/15384047.2021.1926124.
    PubMed    


  36. LEE J, Park S, Woo HY, Kim HS, et al
    Clinicopathological Characteristics of Microscopic Tubal Intraepithelial Metastases from Adenocarcinoma and Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
    In Vivo. 2021;35:2469-2481.
    PubMed    
    Abstract available

  37. SEO I, Jang H
    Aggravation of Hemorrhoids in Patients With Cervical Cancer Undergoing Radiotherapy: A Nationwide Population-based Study.
    In Vivo. 2021;35:2357-2361.
    PubMed    
    Abstract available

  38. KOH HH, Jung YY, Kim HS
    Clinicopathological Characteristics of Gastric-type Endocervical Adenocarcinoma Misdiagnosed as an Endometrial, Ovarian or Extragenital Malignancy, or Mistyped as Usual-type Endocervical Adenocarcinoma.
    In Vivo. 2021;35:2261-2273.
    PubMed    
    Abstract available

  39. MENEUR C, Eswaran S, Adiga D, S S, et al
    Analysis of Nuclear Encoded Mitochondrial Gene Networks in Cervical Cancer.
    Asian Pac J Cancer Prev. 2021;22:1799-1811.
    PubMed    
    Abstract available

  40. OSEI EA, Ninon AP, Gaogli JE, Boadi EO, et al
    "I Just Went for the Screening, But I Did Not Go for the Results". Utilization of Cervical Cancer Screening and Vaccination among Females at Oyibi Community.
    Asian Pac J Cancer Prev. 2021;22:1789-1797.
    PubMed    
    Abstract available

  41. M R, Jose SP, Im K, S S, et al
    Curcumin-Galactomannoside Complex inhibits the Proliferation of Human Cervical Cancer Cells: Possible Role in Cell Cycle Arrest and Apoptosis.
    Asian Pac J Cancer Prev. 2021;22:1713-1720.
    PubMed    
    Abstract available

  42. HAMASHIMA C, Sasaki S, Hosono S, Hoshi K, et al
    National Data Analysis and Systematic Review for Human Resources for Cervical Cancer Screening in Japan.
    Asian Pac J Cancer Prev. 2021;22:1695-1702.
    PubMed    
    Abstract available

  43. ARAB M, Noei Teymoordash S, Talayeh M, Ghavami B, et al
    Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.
    Asian Pac J Cancer Prev. 2021;22:1667-1670.
    PubMed    
    Abstract available

  44. CHEN X, Yu J, Zhao H, Hu Y, et al
    Laparoscopic Radical Hysterectomy Results in Higher Recurrence Rate Versus Open Abdominal Surgery for Stage IB1 Cervical Cancer Patients With Tumor Size Less Than 2 Centimeter: A Retrospective Propensity Score-Matched Study.
    Front Oncol. 2021;11:683231.
    PubMed    
    Abstract available

  45. HUANG C, Liang J, Lin S, Wang D, et al
    N(6)-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1.
    Front Oncol. 2021;11:666597.
    PubMed    
    Abstract available

  46. ALSOUS MM, Ali A, Al-Azzam S, Karasneh R, et al
    Knowledge about cervical cancer and awareness about human papillomavirus vaccination among medical students in Jordan.
    PeerJ. 2021;9:e11611.
    PubMed    
    Abstract available

  47. KOL A, Lubbers JM, Terwindt ALJ, Workel HH, et al
    Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer.
    Oncoimmunology. 2021;10:1936391.
    PubMed    
    Abstract available

  48. MKHONTA SS, Shirinde J
    Registered nurses' perspectives on barriers of cervical cancer screening in Swaziland: a qualitative study.
    Pan Afr Med J. 2021;38:295.
    PubMed    
    Abstract available

  49. GOURD E
    COVID-19 pandemic causes cervical cancer screening crisis.
    Lancet Oncol. 2021 Jun 24. pii: S1470-2045(21)00382.
    PubMed    


  50. KUE J, Szalacha L, Rechenberg K, Nolan TS, et al
    Communication Among Southeast Asian Mothers and Daughters About Cervical Cancer Prevention.
    Nurs Res. 2021 Jun 23. pii: 00006199-900000000-99656.
    PubMed    
    Abstract available

  51. MABUCHI S, Shimura K, Matsumoto Y
    The significance of post-radiotherapy parametrial involvement and the necessity of parametrial resection in locally-recurrent or persistent cervical cancer developed after radiotherapy.
    J Gynecol Obstet Hum Reprod. 2021 Jun 22:102190.
    PubMed    
    Abstract available

  52. HUANG L, He Y, Gong Y
    The long-term urinary dysfunction after type C2 radical hysterectomy in patients with cervical cancer.
    J Obstet Gynaecol. 2021 Jun 25:1-4. doi: 10.1080/01443615.2021.1920004.
    PubMed    
    Abstract available

  53. MBOINEKI JF, Wang P, Chen C
    Fundamental Elements in Training Patient Navigators and Their Involvement in Promoting Public Cervical Cancer Screening Knowledge and Practices: A Systematic Review.
    Cancer Control. 2021;28:10732748211026670.
    PubMed    
    Abstract available

  54. WANG X, Zhang C, Gong M, Jiang C, et al
    A Novel Identified Long Non-coding RNA, lncRNA MEF2C-AS1, Inhibits Cervical Cancer via Regulation of miR-592/RSPO1.
    Front Mol Biosci. 2021;8:687113.
    PubMed    
    Abstract available

  55. ZHANG B, Hong S, Zhang G, Rong F, et al
    Clinical application of the 2011 IFCPC colposcope terminology.
    BMC Womens Health. 2021;21:257.
    PubMed    
    Abstract available

  56. BHAT A, Yadav J, Thakur K, Aggarwal N, et al
    Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog-GLI signaling components.
    Cancer Cell Int. 2021;21:319.
    PubMed    
    Abstract available

  57. MENSAH K, Kabore C, Zeba S, Bouchon M, et al
    Implementation of HPV-based screening in Burkina Faso: lessons learned from the PARACAO hybrid-effectiveness study.
    BMC Womens Health. 2021;21:251.
    PubMed    
    Abstract available

  58. ZHU X, Li X, Ong K, Zhang W, et al
    Hybrid AI-assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears.
    Nat Commun. 2021;12:3541.
    PubMed    
    Abstract available

  59. UWINS C, Cyriac S, Bhandoria G
    HPV vaccine: Expanding indications and global disparity.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00677.
    PubMed    


  60. CHYDERIOTIS S, Sicsic J, Raude J, Bonmarin I, et al
    Optimising HPV vaccination communication to adolescents: A discrete choice experiment.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00656.
    PubMed    
    Abstract available

  61. LI Y, Lu S, Wang S, Peng X, et al
    Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses.
    J Transl Med. 2021;19:222.
    PubMed    
    Abstract available

  62. JANS L, Zetterstrom K, Bergengren L, Helenius G, et al
    The value of adding a single co-test in HPV primary screening.
    Prev Med. 2021;149:106617.
    PubMed    
    Abstract available

  63. TAKSLER GB, Peterse EFP, Willems I, Ten Haaf K, et al
    Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    JAMA Oncol. 2021;7:885-894.
    PubMed    
    Abstract available

  64. CANG W, Gu L, Hong Z, Wu A, et al
    Effectiveness of photodynamic therapy with 5-aminolevulinic acid on HPV clearance in women without cervical lesions.
    Photodiagnosis Photodyn Ther. 2021;34:102293.
    PubMed    
    Abstract available

  65. ARON J, Albert PS, Wentzensen N, Cheung LC, et al
    Hidden mover-stayer model for disease progression accounting for misclassified and partially observed diagnostic tests: Application to the natural history of human papillomavirus and cervical precancer.
    Stat Med. 2021;40:3460-3476.
    PubMed    
    Abstract available

  66. SCHECK SM, Liddle C, Wood Z, Lockett B, et al
    Five-year follow-up after cervical cytology and histology discordance: A retrospective cohort study.
    Aust N Z J Obstet Gynaecol. 2021;61:424-429.
    PubMed    
    Abstract available

  67. MURPHY KA, Stone EM, Presskreischer R, McGinty EE, et al
    Cancer Screening Among Adults With and Without Serious Mental Illness: A Mixed Methods Study.
    Med Care. 2021;59:327-333.
    PubMed    
    Abstract available

  68. WENTZENSEN N, Chirenje ZM, Prendiville W
    Treatment approaches for women with positive cervical screening results in low-and middle-income countries.
    Prev Med. 2021;144:106439.
    PubMed    
    Abstract available

  69. TSU VD, LaMontagne DS, Atuhebwe P, Bloem PN, et al
    National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects.
    Prev Med. 2021;144:106335.
    PubMed    
    Abstract available

  70. KUTER BJ, Garland SM, Giuliano AR, Stanley MA, et al
    Current and future vaccine clinical research with the licensed 2-, 4-, and 9-valent VLP HPV vaccines: What's ongoing, what's needed?
    Prev Med. 2021;144:106321.
    PubMed    
    Abstract available

  71. MODZELEWSKA B, Jozwik M, Kleszczewski T, Sulkowski S, et al
    Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies.
    Gynecol Obstet Invest. 2021;86.
    PubMed    
    Abstract available

  72. OHNO O, Sato K, Honma R, Chiba R, et al
    Antiapoptotic activity of methyl (3R,4E,6Z,15E)-3-hydroxyoctadecatrienoate in human cervical carcinoma HeLa cells.
    Biosci Biotechnol Biochem. 2021;85:228-232.
    PubMed    
    Abstract available

  73. MENG Z, Zhao Z, Li B, Su F, et al
    A Cervical Histopathology Dataset for Computer Aided Diagnosis of Precancerous Lesions.
    IEEE Trans Med Imaging. 2021;40:1531-1541.
    PubMed    
    Abstract available

  74. OBERMAIR HM, Bennett KF, Brotherton JML, Smith MA, et al
    Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists.
    Aust N Z J Obstet Gynaecol. 2021 Jan 29. doi: 10.1111/ajo.13310.
    PubMed    
    Abstract available

  75. RAN R, Wang M, Li X, Liu Q, et al
    A prospective study of photodynamic therapy for cervical squamous intraepithelial lesion.
    Photodiagnosis Photodyn Ther. 2021;34:102185.
    PubMed    
    Abstract available

  76. PENG G, Dong H, Liang T, Li L, et al
    Diagnosis of cervical precancerous lesions based on multimodal feature changes.
    Comput Biol Med. 2021;130:104209.
    PubMed    
    Abstract available

  77. BRANDT HM, Vanderpool RC, Pilar M, Zubizarreta M, et al
    A narrative review of HPV vaccination interventions in rural U.S. communities.
    Prev Med. 2021;145:106407.
    PubMed    
    Abstract available

  78. BRUNI L, Saura-Lazaro A, Montoliu A, Brotons M, et al
    HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.
    Prev Med. 2021;144:106399.
    PubMed    
    Abstract available

  79. SUNDSTROM K, Herweijer E, Wang J
    Cervical screening in high-income countries: the need for quality assurance, adjunct biomarkers and rational adaptation to HPV vaccination.
    Prev Med. 2021;144:106382.
    PubMed    
    Abstract available

  80. CALISKAN E, Coskun SK, Ozturk CE, Cangur S, et al
    Analysis of HPV Genotypes and Liquid-Based Cervical Cytology: Results from a Tertiary Academic Center in Northwestern Turkey.
    Jpn J Infect Dis. 2021;74:69-72.
    PubMed    
    Abstract available

  81. PATERSON P, Mounier-Jack S, Saliba V, Yarwood J, et al
    Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls' HPV vaccination programme in England.
    J Public Health (Oxf). 2021;43:189-196.
    PubMed    
    Abstract available

  82. OLTHOF EP, van der Aa MA, Adam JA, Stalpers LJA, et al
    The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review.
    Int J Clin Oncol. 2021 Jul 9. pii: 10.1007/s10147-021-01980.
    PubMed    
    Abstract available

  83. QU L, Liu B, Bi X, Liu C, et al
    CLIC1 promotes the progression of cervical cancer through the PTEN / PI3K / AKT pathway.
    Panminerva Med. 2021 Jul 9. pii: S0031-0808.21.04430.
    PubMed    


  84. CHEN R, He P
    Long noncoding RNA HOXA-AS2 accelerates cervical cancer by the miR-509-3p/BTN3A1 axis.
    J Pharm Pharmacol. 2021 Jul 8. pii: 6317732. doi: 10.1093.
    PubMed    
    Abstract available

  85. WASSIE M, Fentie B, Asefa T
    Determinants of Mortality among Cervical Cancer Patients Attending in Tikur Anbessa Specialized Hospital, Ethiopia: Institutional-Based Retrospective Study.
    J Oncol. 2021;2021:9916050.
    PubMed    
    Abstract available

  86. SUN Z, Hu J, Hu K, Tang M, et al
    [Role of long noncoding RNA SNHG3 in regulating proliferation, migration and invasion of cervical cancer SiHa cells].
    Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:931-936.
    PubMed    
    Abstract available

  87. MENG D, Jin H, Zhang X, Yan W, et al
    Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer.
    Cancer Cell Int. 2021;21:362.
    PubMed    
    Abstract available

  88. LIU Y, Fu H, Zuo L
    Synergistic Cytotoxicity Effect of 5-fluorouracil and SHP2 Inhibitor Demethylincisterol A3 on Cervical Cancer Cell.
    Anticancer Agents Med Chem. 2021 Jul 8. pii: ACAMC-EPUB-116578.
    PubMed    
    Abstract available

  89. YU MM, Wang GJ, Wu KH, Xue SL, et al
    MicroRNA-373-3p inhibits the growth of cervical cancer by targeting AKT1 both in vitro and in vivo.
    Acta Biochim Pol. 2021 Jul 8. pii: 5446. doi: 10.18388/abp.2020_5446.
    PubMed    
    Abstract available

  90. LALISCIA C, Gadducci A, Mattioni R, Orlandi F, et al
    MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
    Tumori. 2021 Jul 8:3008916211014274. doi: 10.1177/03008916211014274.
    PubMed    
    Abstract available

  91. GONG G, Shen YL, Lan HY, Jin JM, et al
    The Cyr61 Is a Potential Target for Rotundifuran, a Natural Labdane-Type Diterpene from Vitex trifolia L., to Trigger Apoptosis of Cervical Cancer Cells.
    Oxid Med Cell Longev. 2021;2021:6677687.
    PubMed    
    Abstract available

  92. YANG X, Siddique A, Khan AA, Wang Q, et al
    Chlamydia Trachomatis Infection: Their potential implication in the Etiology of Cervical Cancer.
    J Cancer. 2021;12:4891-4900.
    PubMed    
    Abstract available

  93. YAO Z, Shu L, Yi Y, Qiao L, et al
    Hsa_circRNA_000543 Predicts Poor Prognosis and Promotes Cervical Cancer Cell Progression Through Regulating miR-567/ZNF268 Axis.
    Cancer Manag Res. 2021;13:5211-5222.
    PubMed    
    Abstract available

  94. MENDOZA RP, Haidary T, Gabutan E, Zhou YY, et al
    Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer.
    Sci Rep. 2021;11:14064.
    PubMed    
    Abstract available

  95. ZHU C, Zhang C, Cui X, Wu J, et al
    Trichosanthin inhibits cervical cancer by regulating oxidative stress-induced apoptosis.
    Bioengineered. 2021;12:2779-2790.
    PubMed    
    Abstract available

  96. HU C, Han Y, Zhu G, Li G, et al
    Kruppel-like factor 5-induced overexpression of long non-coding RNA DANCR promotes the progression of cervical cancer via repressing microRNA-145-3p to target ZEB1.
    Cell Cycle. 2021 Jul 8:1-14. doi: 10.1080/15384101.2021.1941625.
    PubMed    
    Abstract available

  97. DSOUZA JP, Van den Broucke S, Pattanshetty S, Dhoore W, et al
    The application of health behavior theories to promote cervical cancer screening uptake.
    Public Health Nurs. 2021 Jul 7. doi: 10.1111/phn.12944.
    PubMed    
    Abstract available

  98. KIESEL M, Sauer S, Lob S, Herbert SL, et al
    Total Mesometrial Resection With (Neo)Adjuvant Chemotherapy in Locally Advanced Cervical Cancer: A Tumor Response Score.
    Anticancer Res. 2021;41:3543-3560.
    PubMed    
    Abstract available

  99. SHAM N, Qin C, Zhu Z, Redington CG, et al
    Raspberry Extract With Potential Antitumor Activity Against Cervical Cancer.
    Anticancer Res. 2021;41:3343-3348.
    PubMed    
    Abstract available

  100. WEN S, Xing W, Gao L, Zhao S, et al
    Effect of Superparamagnetic DMSO@gamma-Fe(2)O(3) Combined with Carmustine on Cervical Cancer.
    J Nanosci Nanotechnol. 2021;21:6196-6204.
    PubMed    
    Abstract available

  101. FRIEBEL-KLINGNER TM, Luckett R, Bazzett-Matabele L, Ralefala TB, et al
    Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana.
    BMC Womens Health. 2021;21:267.
    PubMed    
    Abstract available

  102. GUO M, Xu J, Du J
    Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis.
    BMC Public Health. 2021;21:1329.
    PubMed    
    Abstract available

  103. KOHLER RE, Roncarati JS, Aguiar A, Chatterjee P, et al
    Trauma and cervical cancer screening among women experiencing homelessness: A call for trauma-informed care.
    Womens Health (Lond). 2021;17:17455065211029238.
    PubMed    
    Abstract available

  104. LIU XX, Bao QX, Li YM, Zhang YH, et al
    The promotion of cervical cancer progression by signal transducer and activator of transcription 1-induced up-regulation of lncRNA MEOX2-AS1 as a competing endogenous RNA through miR-143-3p/VDAC1 pathway.
    Bioengineered. 2021;12:3322-3335.
    PubMed    
    Abstract available

  105. WEI L, Xie X, Liu J, Qiao Y, et al
    Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China.
    Indian J Gynecol Oncol. 2021;19:51.
    PubMed    
    Abstract available

  106. HOU J, Chen C, Hu Y, Gong Q, et al
    Identify Function of WASL in Prognosis of Cervical Cancer Based on Omics Data.
    Front Cell Dev Biol. 2021;9:670890.
    PubMed    
    Abstract available

  107. ZHANG XR, Li ZQ, Sun LX, Liu P, et al
    Cohort Profile: Chinese Cervical Cancer Clinical Study.
    Front Oncol. 2021;11:690275.
    PubMed    
    Abstract available

  108. ZHAO W, Xiao Y, Zhao W, Yang Q, et al
    Survival Outcomes in Patients With 2018 FIGO Stage IA2-IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis.
    Front Oncol. 2021;11:682849.
    PubMed    
    Abstract available

  109. BAO C, An N, Xie H, Xu L, et al
    Identifying Potential Neoantigens for Cervical Cancer Immunotherapy Using Comprehensive Genomic Variation Profiling of Cervical Intraepithelial Neoplasia and Cervical Cancer.
    Front Oncol. 2021;11:672386.
    PubMed    
    Abstract available

  110. CYR PR, Pedersen K, Iyer AL, Bundorf MK, et al
    Providing more balanced information on the harms and benefits of cervical cancer screening: A randomized survey among US and Norwegian women.
    Prev Med Rep. 2021;23:101452.
    PubMed    
    Abstract available

  111. MUNGO C, Barker E, Randa M, Ambaka J, et al
    Integration of cervical cancer screening into HIV/AIDS care in low-income countries: a moral imperative.
    Ecancermedicalscience. 2021;15:1237.
    PubMed    
    Abstract available

  112. HICKS ML, Mutombo A, YouYou TG, Anaclet MM, et al
    Building workforce capacity for the surgical management of cervical cancer in a fragile, low-income African nation-Democratic Republic of the Congo.
    Ecancermedicalscience. 2021;15:1232.
    PubMed    
    Abstract available

  113. TOYOSHIMA M, Shimada M, Sasaki S, Ishibashi M, et al
    A Single Arm Prospective Pilot Study Examining the Efficacy and Safety of Bevacizumab Single Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Advanced or Recurrent Cervical Cancer.
    Tohoku J Exp Med. 2021;254:145-153.
    PubMed    
    Abstract available

  114. DIAZ-FEIJOO B, Acosta U, Torne A, Gil-Ibanez B, et al
    Laparoscopic debulking of enlarged pelvic nodes during surgical paraaortic staging in locally advanced cervical cancer: a retrospective comparative cohort study.
    J Minim Invasive Gynecol. 2021 Jul 1. pii: S1553-4650(21)00311.
    PubMed    
    Abstract available

  115. CAMPBELL C, Sommerfield T, Clark GRC, Porteous L, et al
    COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.
    Prev Med. 2021;151:106606.
    PubMed    
    Abstract available

  116. WENTZENSEN N, Clarke MA, Perkins RB
    Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities.
    Prev Med. 2021;151:106596.
    PubMed    
    Abstract available

  117. WALKER MJ, Meggetto O, Gao J, Espino-Hernandez G, et al
    Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.
    Prev Med. 2021;151:106586.
    PubMed    
    Abstract available

  118. SAWAYA GF, Holt HK, Lamar R, Perron-Burdick M, et al
    Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California.
    Prev Med. 2021;151:106569.
    PubMed    
    Abstract available

  119. DEGROFF A, Miller J, Sharma K, Sun J, et al
    COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.
    Prev Med. 2021;151:106559.
    PubMed    
    Abstract available

  120. YANG Y, Li Y, Qi R, Zhang L, et al
    Constructe a novel 5 hypoxia genes signature for cervical cancer.
    Cancer Cell Int. 2021;21:345.
    PubMed    
    Abstract available

  121. KHATIWADA M, Kartasasmita C, Mediani HS, Delprat C, et al
    Knowledge, Attitude and Acceptability of the Human Papilloma Virus Vaccine and Vaccination Among University Students in Indonesia.
    Front Public Health. 2021;9:616456.
    PubMed    
    Abstract available

  122. SUMARMI S, Hsu YY, Cheng YM, Lee SH, et al
    Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
    Reprod Health. 2021;18:138.
    PubMed    
    Abstract available

  123. CHU H, Ko LK, Ibrahim A, Bille Mohamed F, et al
    The impact of an educational forum intervention on East African mothers' HPV vaccine-related knowledge, attitudes, and intentions to vaccinate their adolescent children.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00593.
    PubMed    
    Abstract available

  124. SMITH MA, Burger EA, Castanon A, de Kok IMCM, et al
    Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis.
    Prev Med. 2021;151:106623.
    PubMed    
    Abstract available

  125. BASU P, Lucas E, Zhang L, Muwonge R, et al
    Leveraging vertical COVID-19 investments to improve monitoring of cancer screening programme - A case study from Bangladesh.
    Prev Med. 2021;151:106624.
    PubMed    
    Abstract available

  126. GLENN BA, Nonzee NJ, Tieu L, Pedone B, et al
    Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00454.
    PubMed    
    Abstract available

  127. SKORSTENGAARD M, Lynge E, Napolitano G, Blaakaer J, et al
    Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark.
    Hum Reprod. 2021 May 11. pii: 6273654. doi: 10.1093.
    PubMed    
    Abstract available

  128. CASTANON A, Rebolj M, Burger EA, de Kok IMCM, et al
    Cervical screening during the COVID-19 pandemic: optimising recovery strategies.
    Lancet Public Health. 2021;6:e522-e527.
    PubMed    
    Abstract available

  129. VAZQUEZ-OTERO C, Martinez Tyson D, Vamos CA, Romero-Daza N, et al
    Arguments in favor of and against the HPV vaccine school-entry requirement in Puerto Rico: a content analysis of newspaper media.
    Cancer Causes Control. 2021;32:793-802.
    PubMed    
    Abstract available

  130. ZHANG J, Dai Y, Leng J, Zhu L, et al
    Hysterectomy and bilateral adnexectomy using transvaginal natural orifice transluminal endoscopic surgery: The role of multichannel abdominal PORT and vaginal support ring.
    J Obstet Gynaecol Res. 2021;47:2521-2528.
    PubMed    
    Abstract available

  131. BENABOU K, Khadraoui W, Khader T, Hui P, et al
    Port-Site Metastasis in Gynecological Malignancies.
    JSLS. 2021;25.
    PubMed    
    Abstract available

  132. EBISAWA K, Sugiyama T, Itami M, Maru Y, et al
    A case of cervical clear cell carcinoma with serous component.
    J Obstet Gynaecol Res. 2021;47:2551-2554.
    PubMed    
    Abstract available

  133. ORISAKA S, Nakamura M, Obata T, Iwadare J, et al
    A case of synchronous high-grade cervical intraepithelial neoplasia and metastatic squamous cell carcinomas of unknown primary in rectum.
    J Obstet Gynaecol Res. 2021;47:2555-2559.
    PubMed    
    Abstract available

  134. MATTOSCIO D, Gheit T, Strati K, Venuti A, et al
    Editorial: HPV and Host Interaction.
    Front Cell Infect Microbiol. 2021;11:638005.
    PubMed    


  135. DHILLON SK, Valencak AO, Xu L, Poljak M, et al
    Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework.
    J Clin Microbiol. 2021 Mar 17. pii: JCM.00286-21. doi: 10.1128/JCM.00286.
    PubMed    
    Abstract available

  136. DUAN F, Chen J, Yao H, Wang Y, et al
    Enhanced therapeutic efficacy of Listeria-based cancer vaccine with codon-optimized HPV16 E7.
    Hum Vaccin Immunother. 2021;17:1568-1577.
    PubMed    
    Abstract available

  137. DANIELS V, Prabhu VS, Palmer C, Samant S, et al
    Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States.
    Hum Vaccin Immunother. 2021;17:1943-1951.
    PubMed    
    Abstract available

  138. KPOGHOMOU MA, Geneau M, Menard J, Stiti M, et al
    Assessment of an onco-sexology support and follow-up program in cervical or vaginal cancer patients undergoing brachytherapy.
    Support Care Cancer. 2021;29:4311-4318.
    PubMed    
    Abstract available

  139. KJAER SK, Nygard M, Sundstrom K, Munk C, et al
    Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up.
    Hum Vaccin Immunother. 2021;17:943-949.
    PubMed    
    Abstract available

  140. LEE HJ, Park M, Choi H, Nowakowska A, et al
    Pine Needle Extract Applicable to Topical Treatment for the Prevention of Human Papillomavirus Infection.
    J Microbiol Biotechnol. 2021;31:137-143.
    PubMed    
    Abstract available

  141. HU S, Xu X, Zhu F, Hong Y, et al
    Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial.
    Hum Vaccin Immunother. 2021;17:955-964.
    PubMed    
    Abstract available

  142. BHUYAN PK, Dallas M, Kraynyak K, Herring T, et al
    Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.
    Hum Vaccin Immunother. 2021;17:1288-1293.
    PubMed    
    Abstract available

  143. TOZAWA-ONO A, Kamada M, Teramoto K, Hareyama H, et al
    Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study.
    Hum Vaccin Immunother. 2021;17:950-954.
    PubMed    
    Abstract available

  144. ZHANG X, Wang Z, Ren Z, Li Z, et al
    HPV vaccine acceptability and willingness-related factors among Chinese adolescents: a nation-wide study.
    Hum Vaccin Immunother. 2021;17:1025-1032.
    PubMed    
    Abstract available

  145. WANG W, Lyu J, Li M, Zhang Y, et al
    Quality evaluation of HPV vaccine-related online messages in China: a cross-sectional study.
    Hum Vaccin Immunother. 2021;17:1089-1096.
    PubMed    
    Abstract available

  146. BIEDERMAN E, Donahue K, Sturm L, Champion V, et al
    The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children.
    Hum Vaccin Immunother. 2021;17:1000-1005.
    PubMed    
    Abstract available

  147. NYGARD M, Hansen BT, Kjaer SK, Hortlund M, et al
    Human papillomavirus genotype-specific risks for cervical intraepithelial lesions.
    Hum Vaccin Immunother. 2021;17:972-981.
    PubMed    
    Abstract available

  148. MAI Q, Yang X, Cheng H, Wu G, et al
    Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China.
    Hum Vaccin Immunother. 2021;17:965-971.
    PubMed    
    Abstract available

  149. FRANCK JE, Ringa V, Rigal L, Sassenou J, et al
    Patterns of gynaecological check-up and their association with body mass index within the CONSTANCES cohort.
    J Med Screen. 2021;28:10-17.
    PubMed    
    Abstract available

  150. MCFARLANE SJ, Morgan SE
    Evaluating Culturally-targeted Fear Appeal Messages for HPV Self-Sampling among Jamaican Women: A Qualitative Formative Research Study.
    Health Commun. 2021;36:877-890.
    PubMed    
    Abstract available

  151. ZHANG Y, Ren F, Ni B, Jing T, et al
    Tumor targeting nanoparticle E749-57-HSP110-RGD elicits potent anti-tumor immune response in a CD8-dependent manner in cervical cancer-bearing mouse model.
    Hum Vaccin Immunother. 2021 Jul 16:1-10. doi: 10.1080/21645515.2021.1933875.
    PubMed    
    Abstract available

  152. MARETI E, Dinas CCGCPALEVAPRDADLZK
    Human papillomavirus in breast cancer of patients with cervical intraepithelial neoplasia or cervical cancer history. A systematic review and meta-analysis.
    J BUON. 2021;26:707-713.
    PubMed    
    Abstract available

  153. ATASEVER AKKAS E, Altundag MB
    Long-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary application in cervical cancer.
    J BUON. 2021;26:698-706.
    PubMed    
    Abstract available

  154. WANG Y, Guo AWJZT
    Curative effect of laparoscopic-assisted vaginal radical trachelectomy combined with pelvic lymph node dissection on early-stage cervical cancer.
    J BUON. 2021;26:684-690.
    PubMed    
    Abstract available

  155. WANG A, Chen YWJZJ
    MicroRNA-186-5p inhibits the metastasis of cervical cancer by targeting FZD3.
    J BUON. 2021;26:677-683.
    PubMed    
    Abstract available

  156. AISHANJIANG D, Hou LHMNQ
    Clinical analysis of uterine arterial interventional chemoembolization combined with radiotherapy in mid-advanced cervical cancer.
    J BUON. 2021;26:656-662.
    PubMed    
    Abstract available

  157. NIKOOKAR E, Naderi E, Rahnavard A
    Cervical Cancer Prediction by Merging Features of Different Colposcopic Images and Using Ensemble Classifier.
    J Med Signals Sens. 2021;11:67-78.
    PubMed    
    Abstract available

  158. PELLEGRINI R, Reinert T, Barrios CH
    Cost-effectiveness of breast, lung, colon, prostate and cervical cancer outcomes in Brazil: a worldwide comparison.
    Ecancermedicalscience. 2021;15:1243.
    PubMed    
    Abstract available

  159. ZHAO M, Gu RY, Ding SR, Luo L, et al
    Risk factors of cervical cancer among ethnic minorities in Yunnan Province, China: a case-control study.
    Eur J Cancer Prev. 2021 Jul 8. pii: 00008469-900000000-99031.
    PubMed    
    Abstract available

  160. WANG Y, Cai YB, James W, Zhou JL, et al
    Human papillomavirus distribution and cervical cancer epidemiological characteristics in rural population of Xinjiang, China.
    Chin Med J (Engl). 2021 Jul 14. pii: 00029330-900000000-98513.
    PubMed    
    Abstract available

  161. WILLIAMSON CW, Liu HC, Mayadev J, Mell LK, et al
    Advances in External Beam Radiation Therapy and Brachytherapy for Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2021 Jul 12. pii: S0936-6555(21)00257.
    PubMed    
    Abstract available

  162. DOMENICI L, Tonacci A, Aretini P, Garibaldi S, et al
    Inflammatory Biomarkers as Promising Predictors of Prognosis in Cervical Cancer Patients.
    Oncology. 2021 Jul 15:1-9. doi: 10.1159/000517320.
    PubMed    
    Abstract available

  163. ABILA DB, Wasukira SB, Ainembabazi P, Wabinga H, et al
    Burden of Risk Factors for Cervical Cancer Among Women Living in East Africa: An Analysis of the Latest Demographic Health Surveys Conducted Between 2014 and 2017.
    JCO Glob Oncol. 2021;7:1116-1128.
    PubMed    
    Abstract available

  164. HUANG H, Feng YL, Liu JH
    Sequential Chemoradiotherapy vs Concurrent Chemoradiotherapy or Radiotherapy Alone in Adjuvant Treatment for Patients With Cervical Cancer-Reply.
    JAMA Oncol. 2021 Jul 15. pii: 2781892. doi: 10.1001/jamaoncol.2021.2113.
    PubMed    


  165. SARI SY, Kahvecioglu A, Yildiz F
    Sequential Chemoradiotherapy vs Concurrent Chemoradiotherapy or Radiotherapy Alone in Adjuvant Treatment for Patients With Cervical Cancer.
    JAMA Oncol. 2021 Jul 15. pii: 2781893. doi: 10.1001/jamaoncol.2021.2110.
    PubMed    


  166. COHEN D, Hazut Krauthammer S, Levine C, Even-Sapir E, et al
    [STAGING CERVICAL CANCER USING PET-CT AND PET-MRI].
    Harefuah. 2021;160:442-447.
    PubMed    
    Abstract available

  167. XIE H, Wang J, Wang B
    Circular RNA Circ_0003221 Promotes Cervical Cancer Progression by Regulating miR-758-3p/CPEB4 Axis.
    Cancer Manag Res. 2021;13:5337-5350.
    PubMed    
    Abstract available

  168. XIA Y, Wang G, Jiang M, Liu X, et al
    A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway.
    Onco Targets Ther. 2021;14:4047-4060.
    PubMed    
    Abstract available

  169. THOMSEN LT, Kjaer SK
    Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China.
    BMC Med. 2021;19:165.
    PubMed    


  170. ZHAO Y, Bao H, Ma L, Song B, et al
    Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study.
    BMC Med. 2021;19:164.
    PubMed    
    Abstract available

  171. APHALE S, Shinde K, Pandita S, Mahajan M, et al
    Panchvalkala, a traditional Ayurvedic formulation, exhibits antineoplastic and immunomodulatory activity in cervical cancer cells and C57BL/6 mouse papilloma model.
    J Ethnopharmacol. 2021 Jul 11:114405. doi: 10.1016/j.jep.2021.114405.
    PubMed    
    Abstract available

  172. SWAMIDAS J, Pradhan S, Chopra S, Panda S, et al
    Development and clinical validation of Knowledge-based planning for Volumetric Modulated Arc Therapy of cervical cancer including pelvic and para aortic fields.
    Phys Imaging Radiat Oncol. 2021;18:61-67.
    PubMed    
    Abstract available

  173. GUO H, Li J, Fan F, Zhou P, et al
    LINC00707 Regulates miR-382-5p/VEGFA Pathway to Enhance Cervical Cancer Progression.
    J Immunol Res. 2021;2021:5524632.
    PubMed    
    Abstract available

  174. LI G, Wang X, Liu G
    PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
    Biomed Res Int. 2021;2021:5512340.
    PubMed    
    Abstract available

  175. HAAS JS, Vogeli C, Yu L, Atlas SJ, et al
    Patient, provider, and clinic factors associated with the use of cervical cancer screening.
    Prev Med Rep. 2021;23:101468.
    PubMed    
    Abstract available

  176. CHEN Q, Wang Y, Dang H, Wu X, et al
    MicroRNA-148a-3p inhibits the proliferation of cervical cancer cells by regulating the expression levels of DNMT1 and UTF1.
    Oncol Lett. 2021;22:617.
    PubMed    
    Abstract available

  177. JIANG J, Xu H, Wang Y, Lu H, et al
    Identification and Validation of Autophagy-Related Gene Nomograms to Predict the Prognostic Value of Patients with Cervical Cancer.
    J Oncol. 2021;2021:5583400.
    PubMed    
    Abstract available

  178. LOCSEI Z, Sebestyen K, Sebestyen Z, Feher E, et al
    IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study.
    Pathol Oncol Res. 2021;27:608446.
    PubMed    
    Abstract available

  179. IYENGAR S, Kantor K, Cyriac S, Remadevi K, et al
    No family should suffer from cervical cancer twice - the palliative care role in HPV prevention.
    J Pain Symptom Manage. 2021 Jul 10. pii: S0885-3924(21)00420.
    PubMed    
    Abstract available

  180. HOSIER H, Sheth SS, Oliveira CR, Perley LE, et al
    Unindicated Cervical Cancer Screening in Adolescent Females within a Large Healthcare System in the United States.
    Am J Obstet Gynecol. 2021 Jul 10. pii: S0002-9378(21)00791.
    PubMed    
    Abstract available

  181. RUIZ FJ, Inkman M, Rashmi R, Muhammad N, et al
    HPV transcript expression affects cervical cancer response to chemoradiation.
    JCI Insight. 2021 Jul 13. pii: e138734. doi: 10.1172/jci.insight.138734.
    PubMed    
    Abstract available

  182. JAVANI JOUNI F, Abdollahi V, Zadehmodarres S, Abbasinia H, et al
    Combination of cisplatin treatment and photodynamic therapy attenuates cisplatin-induced cell toxicity in A2780 and A2780-CP cervical cancer cell lines.
    Lasers Med Sci. 2021 Jul 13. pii: 10.1007/s10103-021-03369.
    PubMed    
    Abstract available

  183. ZHU Y, Wang C, Li M, Yang X, et al
    Targeting of MNK/eIF4E overcomes chemoresistance in cervical cancer.
    J Pharm Pharmacol. 2021 Jul 13. pii: 6319978. doi: 10.1093.
    PubMed    
    Abstract available

  184. CHUNDRIGER Q, Chishti U, Idrees R
    Squamous cell carcinoma of uterine cervix metastatic to the axillary lymph node.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  185. JING H, Xiuhong W, Ying Y, Zhenrong L, et al
    Neoadjuvant chemotherapy combined with radical surgery for stage IB2/IIA2 cervical squamous cell carcinoma: a prospective, randomized controlled study of 35 patients.
    World J Surg Oncol. 2021;19:209.
    PubMed    
    Abstract available

  186. LU X, Song X, Hao X, Liu X, et al
    MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1.
    World J Surg Oncol. 2021;19:207.
    PubMed    
    Abstract available

  187. CUDJOE J, Gallo JJ, Sharps P, Budhathoki C, et al
    The Role of Sources and Types of Health Information in Shaping Health Literacy in Cervical Cancer Screening Among African Immigrant Women: A Mixed-Methods Study.
    Health Lit Res Pract. 2021;5:e96-e108.
    PubMed    
    Abstract available

  188. HARASHIMA K, Watanabe S, Okazaki N, Endo D, et al
    Herpes zoster infection mimicking pelvic lymph node metastasis on FDG-PET/CT in a patient with cervical cancer.
    Asia Ocean J Nucl Med Biol. 2021;9:183-187.
    PubMed    
    Abstract available

  189. SHANG C, Huang J, Guo H
    Identification of an Metabolic Related Risk Signature Predicts Prognosis in Cervical Cancer and Correlates With Immune Infiltration.
    Front Cell Dev Biol. 2021;9:677831.
    PubMed    
    Abstract available

  190. LAI YL, Jin YN, Wang X, Qi WX, et al
    The Case Selection for Vaginal Cuff Brachytherapy in Cervical Cancer Patients After Radical Hysterectomy and External Beam Radiation Therapy.
    Front Oncol. 2021;11:685972.
    PubMed    
    Abstract available

  191. ALMOHSEN SS, Alnuaim H, Salim AA, Arabi H, et al
    Pelvic Radiation-Induced Sarcoma With Rhabdomyoblastic Differentiation Following Treatment of Cervical Cancer.
    Cureus. 2021;13:e15428.
    PubMed    
    Abstract available

  192. RAMACHANDRAN B, Murhekar K, Sundersingh S
    SERMs suppresses the growth of ERalpha positive cervical cancer xenografts through predominant inhibition of extra-nuclear ERalpha expression.
    Am J Cancer Res. 2021;11:3335-3353.
    PubMed    
    Abstract available

  193. TAYYAR Y, Idris A, Vidimce J, Ferreira DA, et al
    Alpelisib and radiotherapy treatment enhances Alisertib-mediated cervical cancer tumor killing.
    Am J Cancer Res. 2021;11:3240-3251.
    PubMed    
    Abstract available

  194. HUANG B, Zhu L, Wei H, Shi H, et al
    Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer.
    Front Immunol. 2021;12:678318.
    PubMed    
    Abstract available

  195. SHELLEY CE, Barraclough LH, Nelder CL, Otter SJ, et al
    Adaptive Radiotherapy in the Management of Cervical Cancer: Review of Strategies and Clinical Implementation.
    Clin Oncol (R Coll Radiol). 2021 Jul 8. pii: S0936-6555(21)00227.
    PubMed    
    Abstract available

  196. ZHANG H, He P, Zhou Q, Lu Y, et al
    The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells.
    Cancer Cell Int. 2021;21:369.
    PubMed    
    Abstract available

  197. BAE BK, Park SH, Jeong SY, Chong GO, et al
    Mapping patterns of para-aortic lymph node recurrence in cervical cancer: a retrospective cohort analysis.
    Radiat Oncol. 2021;16:128.
    PubMed    
    Abstract available

  198. LV F, Wang J, Chen H, Sui L, et al
    Enhanced mucosal penetration and efficient inhibition efficacy against cervical cancer of PEGylated docetaxel nanocrystals by TAT modification.
    J Control Release. 2021;336:572-582.
    PubMed    
    Abstract available

  199. DROLET M, Laprise JF, Martin D, Jit M, et al
    Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
    Lancet Infect Dis. 2021 Jul 7. pii: S1473-3099(20)30860.
    PubMed    
    Abstract available

  200. ALTOVA A, Kulhanova I, Bruha L, Lustigova M, et al
    Breast and cervical cancer screening attendance among Czech women.
    Cent Eur J Public Health. 2021;29:90-95.
    PubMed    
    Abstract available

  201. ALBAYRAK A, Akhan AU, Calik N, Capar A, et al
    A whole-slide image grading benchmark and tissue classification for cervical cancer precursor lesions with inter-observer variability.
    Med Biol Eng Comput. 2021 Jul 10. pii: 10.1007/s11517-021-02388.
    PubMed    
    Abstract available

  202. HAMASHIMA C
    Emerging technologies for cervical cancer screening.
    Jpn J Clin Oncol. 2021 Jul 9. pii: 6318553. doi: 10.1093.
    PubMed    
    Abstract available

  203. ZHENG Y, Xie L, Xu S, Yan W, et al
    Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Mol Cell Biochem. 2021 Jul 9. pii: 10.1007/s11010-021-04211.
    PubMed    
    Abstract available

  204. DATCHOUA MOUKAM AM, Embolo Owono MS, Kenfack B, Vassilakos P, et al
    "Cervical cancer screening: awareness is not enough". Understanding barriers to screening among women in West Cameroon-a qualitative study using focus groups.
    Reprod Health. 2021;18:147.
    PubMed    
    Abstract available

  205. GE Y, Liu Y, Cheng Y, Liu Y, et al
    Predictors of recurrence in patients with high-grade cervical intraepithelial neoplasia after cervical conization.
    Medicine (Baltimore). 2021;100:e26359.
    PubMed    
    Abstract available

  206. LUO YH, Zhang L, Wang MY, Fang J, et al
    Anti-cancer effects of baicalein on cervical carcinoma cells through down-regulation of the ERK/p38/MAPK pathway.
    J Biol Regul Homeost Agents. 2021;35:945-952.
    PubMed    
    Abstract available

  207. ENG JCL, Er JBT, Wan CSY, Lim YK, et al
    Cervical screening in foreign domestic workers in Singapore.
    Ann Acad Med Singap. 2021;50:135-140.
    PubMed    
    Abstract available

  208. PEI XD, He ZL, Yao HL, Xiao JS, et al
    6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway.
    Eur J Nutr. 2021;60:2781-2793.
    PubMed    
    Abstract available

  209. KASSIS S, Grondin M, Averill-Bates DA
    Heat shock increases levels of reactive oxygen species, autophagy and apoptosis.
    Biochim Biophys Acta Mol Cell Res. 2021;1868:118924.
    PubMed    
    Abstract available

  210. YANG X, Wang J, Wang Y, Fan Q, et al
    Surgical Technique Based on Space Anatomy for Laparoscopic Radical Trachelectomy with Uterine Artery Preservation.
    J Laparoendosc Adv Surg Tech A. 2021;31:705-709.
    PubMed    
    Abstract available

  211. RISLEY C, Stewart MW, Geisinger KR, Hiser LM, et al
    STRIDES - STudying Risk to Improve DisparitiES in Cervical Cancer in Mississippi - Design and baseline results of a Statewide Cohort Study.
    Prev Med. 2021 Jul 19:106740. doi: 10.1016/j.ypmed.2021.106740.
    PubMed    
    Abstract available

  212. VOJTISEK R, Baxa J, Hosek P, Ferda J, et al
    Reply to: Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtisek et al.
    Strahlenther Onkol. 2021 Jul 22. pii: 10.1007/s00066-021-01818.
    PubMed    


  213. SHOKRI JAMNANI A, Rezapour A, Moradi N, Langarizadeh M, et al
    Willingness to pay for and acceptance of cervical cancer prevention methods: A systematic review and meta-analysis.
    Med J Islam Repub Iran. 2021;35:81.
    PubMed    
    Abstract available

  214. ZHANG CL, Xie DQ, Ao LN, Zhu L, et al
    A comparative analysis of high-flux and low-flux dialysis in cervical cancer patients with obstructive renal failure showing no significantly improved renal function after catheterisation.
    Pak J Med Sci. 2021;37:1014-1019.
    PubMed    
    Abstract available

  215. O'BRIEN KM, Weinberg CR, D'Aloisio AA, Moore KR, et al
    The association between douching, genital talc use, and the risk of prevalent and incident cervical cancer.
    Sci Rep. 2021;11:14836.
    PubMed    
    Abstract available


  216. [Chinese expert consensus on nerve-sparing radical hysterectomy for cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2021;43:736-742.
    PubMed    
    Abstract available

  217. CHONG GO, Jee-Young Park N, Han HS, Cho J, et al
    Intratumoral budding: A novel prognostic biomarker for tumor recurrence and a potential predictor of nodal metastasis in uterine cervical cancer.
    Eur J Surg Oncol. 2021 Jul 17. pii: S0748-7983(21)00630.
    PubMed    
    Abstract available

  218. ZHENG Q, Zhang J, Zhang T, Liu Y, et al
    Hsa_circ_0000520 overexpression increases CDK2 expression via miR-1296 to facilitate cervical cancer cell proliferation.
    J Transl Med. 2021;19:314.
    PubMed    
    Abstract available

  219. KASTING ML, Haggstrom DA, Lee JL, Dickinson SL, et al
    Financial hardship is associated with lower uptake of colorectal, breast, and cervical cancer screenings.
    Cancer Causes Control. 2021 Jul 20. pii: 10.1007/s10552-021-01465.
    PubMed    
    Abstract available

  220. SATHISHKUMAR K, N V, Badwe RA, Deo SVS, et al
    Trends in breast and cervical cancer in India under National Cancer Registry Programme: An Age-Period-Cohort analysis.
    Cancer Epidemiol. 2021;74:101982.
    PubMed    
    Abstract available

  221. INTURI R, Jemth P
    CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells.
    Virology. 2021;562:92-102.
    PubMed    
    Abstract available

  222. HE F, Zu S, Chen X, Liu J, et al
    Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.
    Cancer Med. 2021 Jul 18. doi: 10.1002/cam4.4075.
    PubMed    
    Abstract available

  223. SUI X, Wang Y, Liu H
    hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.
    Mol Med Rep. 2021;24.
    PubMed    
    Abstract available

  224. LI L, Gao H, Wang D, Jiang H, et al
    Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer.
    Front Mol Biosci. 2021;8:624951.
    PubMed    
    Abstract available

  225. SHIN MB, Liu G, Mugo N, Garcia PJ, et al
    A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities.
    Front Public Health. 2021;9:670032.
    PubMed    
    Abstract available

  226. WEI M, Chen Y, Du W
    LncRNA LINC00858 enhances cervical cancer cell growth through miR-3064-5p/ VMA21 axis.
    Cancer Biomark. 2021 Jul 9. pii: CBM200033. doi: 10.3233/CBM-200033.
    PubMed    
    Abstract available

  227. MAHANTSHETTY U, Lavanya G, Grover S, Akinfenwa CA, et al
    Incidence, Treatment and Outcomes of Cervical Cancer in Low- and Middle-income Countries.
    Clin Oncol (R Coll Radiol). 2021 Jul 14. pii: S0936-6555(21)00260.
    PubMed    
    Abstract available

  228. NGUYEN-XUAN HT, Benoit L, Dabi Y, Touboul C, et al
    How to predict para-aortic node involvement in advanced cervical cancer? Development of a predictive score. A FRANCOGYN study.
    Eur J Surg Oncol. 2021 Jul 8. pii: S0748-7983(21)00598.
    PubMed    
    Abstract available

  229. CHEN C, Shen N, Chen Y, Jiang P, et al
    LncCCLM inhibits lymphatic metastasis of cervical cancer by promoting STAU1-mediated IGF-1 mRNA degradation.
    Cancer Lett. 2021;518:169-179.
    PubMed    
    Abstract available

  230. JILLAPALLI R, Radhakrishnan K
    Cervical Cancer Screening Behaviors Among Asian Indians in the United States: A Systematic Review.
    J Immigr Minor Health. 2021 Jul 17. pii: 10.1007/s10903-021-01237.
    PubMed    
    Abstract available

  231. MINHAS S, Kashif M, Rehman Z, Pasha MB, et al
    Distribution of High-risk Human Papillomavirus Genotypes in Cervical Secretions in Punjab.
    J Coll Physicians Surg Pak. 2021;30:786-791.
    PubMed    
    Abstract available

  232. BEE KJ, Gradissimo A, Chen Z, Harari A, et al
    Genetic and Epigenetic Variations of HPV52 in Cervical Precancer.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  233. WANG X, Du T, Shi X, Wu K, et al
    Awareness and Knowledge about Human Papilloma Virus Infection among Students at Secondary Occupational Health School in China.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  234. RANIERI D, French D, Raffa S, Guttieri L, et al
    Expression of the E5 Oncoprotein of HPV16 Impacts on the Molecular Profiles of EMT-Related and Differentiation Genes in Ectocervical Low-Grade Lesions.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  235. SALYER C, Lipnicky A, Bagwell-Gray M, Lorvick J, et al
    Abnormal Pap Follow-Up among Criminal-Legal Involved Women in Three U.S. Cities.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  236. SETAYESH T, Nersesyan A, Kundi M, Misik M, et al
    Impact of infections, preneoplasia and cancer on micronucleus formation in urothelial and cervical cells: A systematic review.
    Mutat Res. 2021;787:108361.
    PubMed    
    Abstract available

  237. CRUICKSHANK M
    Risk stratification of HPV-positive women in routine cervical screening.
    BJOG. 2021;128:1363.
    PubMed    


  238. WANG M, Hou B, Wang X, Han L, et al
    Diagnostic value of high-risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage.
    Cancer Med. 2021;10:2482-2488.
    PubMed    
    Abstract available

  239. PASRICHA S, Jain K, Kamboj M, Gupta G, et al
    Metastatic micropapillary adenocarcinoma in cervix revealing an occult primary in breast: A diagnostic challenge.
    Indian J Pathol Microbiol. 2021;64:219-221.
    PubMed    


  240. DA Q, Yan Z, Li Z, Han Z, et al
    TAK1 is involved in sodium L-lactate-stimulated p38 signaling and promotes apoptosis.
    Mol Cell Biochem. 2021;476:873-882.
    PubMed    
    Abstract available

  241. MCGEECHAN GJ, James B, Burke S
    'Well that's the most ridiculous thing I have ever heard! No excuse'. A discourse analysis of social media users' othering of non-attenders for cervical screening.
    Psychol Health. 2021;36:290-306.
    PubMed    
    Abstract available

  242. LITWIN TR, Irvin SR, Chornock RL, Sahasrabuddhe VV, et al
    Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis.
    Br J Cancer. 2021;124:831-841.
    PubMed    
    Abstract available

  243. MIX JM, Saraiya M, Thompson TD, Querec TD, et al
    Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33582.
    PubMed    
    Abstract available

  244. JEANNOT E, Latouche A, Bonneau C, Calmejane MA, et al
    Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer.
    Clin Cancer Res. 2021 Jul 1. pii: 1078-0432.CCR-21-0625.
    PubMed    
    Abstract available

  245. CHEUNG M, Fitzpatrick M
    The impact of the CervicalCheck controversy on provision of colposcopy services in Ireland: A cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:228-231.
    PubMed    
    Abstract available

  246. MENG S, Li Z, Chen L, Yang X, et al
    Laparoscopic radical hysterectomy for cervical cancer by pulling the round ligament without a uterine manipulator.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:31-35.
    PubMed    
    Abstract available

  247. PARASKEVAIDIS E, Athanasiou A, Kalliala I, Batistatou A, et al
    Invasive cervical cancer following treatment of pre-invasive lesions: A potential theory based on a small case series.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:56-59.
    PubMed    
    Abstract available

  248. BROOKS SE, Davis EC, Farley JH
    Disparities in pap smear screening follow up: A catalyst for collective action vs. collective despair.
    Gynecol Oncol. 2021;160:361-363.
    PubMed    


  249. SPONHOLTZ SE, Mogensen O, Hildebrandt MG, Schledermann D, et al
    Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
    Gynecol Oncol. 2021 Jul 2. pii: S0090-8258(21)00512.
    PubMed    
    Abstract available

  250. LEVINSON K, Beavis AL, Purdy C, Rositch AF, et al
    Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.
    Gynecol Oncol. 2021 Jun 30. pii: S0090-8258(21)00511.
    PubMed    
    Abstract available

  251. JANSEN EEL, Ivanus U, Jerman T, de Koning HJ, et al
    The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia.
    Gynecol Oncol. 2020 Nov 13. pii: S0090-8258(20)34058.
    PubMed    
    Abstract available

  252. BOGANI G, Raspagliesi F, di Donato V, Brusadelli C, et al
    Spotlight on the role of human papillomavirus vaccines.
    Gynecol Oncol. 2021;160:346-350.
    PubMed    
    Abstract available

  253. BURGER EA, Portnoy A, Campos NG, Sy S, et al
    Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries.
    Int J Cancer. 2020 Jul 24. doi: 10.1002/ijc.33233.
    PubMed    
    Abstract available

  254. RAMIREZ AT, Sanchez GI, Nedjai B, Agudelo MC, et al
    Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country.
    Int J Cancer. 2020 Oct 2. doi: 10.1002/ijc.33314.
    PubMed    
    Abstract available

  255. ZHAO XL, Liu ZH, Zhao S, Hu SY, et al
    Efficacy of point-of-care thermal ablation among high-risk human papillomavirus positive women in China.
    Int J Cancer. 2021;148:1419-1427.
    PubMed    
    Abstract available

  256. MWANAHAMUNTU M, Kapambwe S, Pinder LF, Matambo J, et al
    The use of thermal ablation in diverse cervical cancer 'screen-and-treat' service platforms in Zambia.
    Int J Gynaecol Obstet. 2021 Jul 1. doi: 10.1002/ijgo.13808.
    PubMed    
    Abstract available

  257. MAHANDE MJ, Oneko O, Amour C, Pollie M, et al
    Feasibility and acceptability of human papillomavirus self-sampling in a semi-urban area in northern Tanzania.
    Int J Gynaecol Obstet. 2021;154:113-118.
    PubMed    
    Abstract available

  258. KIM MH, Jung HJ, Park SI, Kim BJ, et al
    Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13574.
    PubMed    
    Abstract available

  259. CHO HW, Hong JH, Lee JK
    Detection of high-risk human papillomavirus infection and treatment of high-grade vaginal intraepithelial neoplasia: A single-institution study.
    Int J Gynaecol Obstet. 2021;154:227-232.
    PubMed    
    Abstract available

  260. MUNGO C, Randa M, Shauri A, Serem D, et al
    Characteristics, stage at presentation, and status of women with cervical cancer at a major referral center in western Kenya.
    Int J Gynaecol Obstet. 2021 Jul 20. doi: 10.1002/ijgo.13831.
    PubMed    
    Abstract available

  261. SPENCER NM, Bos L
    Intracardiac metastatic cervical cancer.
    Int J Gynecol Cancer. 2021;31:1095.
    PubMed    


  262. DYER BA, Feng CH, Eskander R, Sharabi AB, et al
    Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined with Radiation.
    Int J Radiat Oncol Biol Phys. 2020 Sep 14. pii: S0360-3016(20)34287.
    PubMed    
    Abstract available

  263. K JENSEN NB, Potter R, Spampinato S, Fokdal LU, et al
    Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study.
    Int J Radiat Oncol Biol Phys. 2021;109:688-700.
    PubMed    
    Abstract available

  264. MAIMAITIREXIATI G, Tian P, Maimaiti H, Ding L, et al
    Expression and correlation analysis of Skp2 and CBX7 in cervical cancer.
    J Clin Pathol. 2021 Jul 19. pii: jclinpath-2021-207752.
    PubMed    
    Abstract available

  265. WU B, Xi S
    Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    BMC Cancer. 2021;21:733.
    PubMed    
    Abstract available

  266. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
    Correction to: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    BMC Cancer. 2021;21:811.
    PubMed    


  267. QI J, Zhou L, Li D, Yang J, et al
    Oncogenic role of ALX3 in cervical cancer cells through KDM2B-mediated histone demethylation of CDC25A.
    BMC Cancer. 2021;21:819.
    PubMed    
    Abstract available

  268. LI Y, Kong Q, Wei H, Wang Y, et al
    Comparison of the complications between minimally invasive surgery and open surgical treatments for early-stage cervical cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253143.
    PubMed    
    Abstract available

  269. MOISE RK, Balise R, Ragin C, Kobetz E, et al
    Cervical cancer risk and access: Utilizing three statistical tools to assess Haitian women in South Florida.
    PLoS One. 2021;16:e0254089.
    PubMed    
    Abstract available

  270. BEYENE T, Akibu M, Bekele H, Seyoum W, et al
    Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: Unmatched case-control study.
    PLoS One. 2021;16:e0254663.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;